Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China
Clinical trial NCT07073690 · COMPLETED
Trial details
- NCT number
- NCT07073690
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-18
- Primary completion
- 2026-05-12
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.